Table 3 Characteristics of 1356 patients initiating antiretroviral therapy pre- versus post-interventiona
Characteristic | Pre-intervention | Post-intervention | ||
|---|---|---|---|---|
N | % | N | % | |
Total | 678 | 678 | ||
Sex | ||||
Female | 408 | 60.2% | 446 | 65.8% |
Male | 270 | 39.8% | 232 | 34.2% |
Age group | ||||
< 10 years | 30 | 4.4% | 27 | 4.0% |
10–18 years | 20 | 3.0% | 35 | 5.2% |
19–48 years | 542 | 79.9% | 558 | 82.3% |
49+ years | 64 | 9.4% | 54 | 8.0% |
Missing | 22 | 3.2% | 4 | 0.6% |
Time from diagnosis to ART initiation | ||||
< 1 month | – | – | 267 | 39.4% |
1- < 3 months | – | – | 49 | 7.2% |
3- < 6 months | – | – | 28 | 4.1% |
6- < 12 months | – | – | 26 | 3.8% |
12+ months | – | – | 43 | 6.3% |
Missing | – | – | 265 | 39.1% |
Clinical stage at initiation | ||||
I | – | – | 432 | 63.7% |
II | – | – | 168 | 24.8% |
III | – | – | 30 | 4.4% |
IV | – | – | 5 | 0.7% |
Missing | – | – | 43 | 6.3% |
CD4 count at initiation | ||||
< 200 cells/mcL | – | – | 36 | 5.3% |
200- < 350 cells/mcL | – | – | 70 | 10.3% |
350- < 500 cells/mcL | – | – | 73 | 10.8% |
500+ cells/mcL | – | – | 49 | 7.2% |
Missing | – | – | 450 | 66.4% |
Pregnancy/lactation status at initiation | ||||
Pregnant | – | – | 129 | 19.0% |
Lactating | – | – | 15 | 2.2% |
None | – | – | 534 | 78.8% |